维普中文期刊产品整合服务
14篇 您的检索式:作者名="Pedicone"
    题名 作者 年代 出处 被引量
1Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir显示文摘Fred Poordad Jean–Pierre Bronowicki Stuart C. Gordon Stefan Zeuzem Ira M. Jacobson Mark S. Sulkowski Thierry Poynard Timothy R. Morgan Cliona Molony Lisa D. Pedicone Heather L. Sings Margaret H. Burroughs Vilma Sniukiene Navdeep Boparai Venkata S. Goteti 2012Gastroenterology2012,,3:5
2Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:3
3Efficacy and safety of boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis显示文摘Savino Bruno John M. Vierling Rafael Esteban Lisa M. Nyberg Hugo Tanno Zachary Goodman Fred Poordad Bruce Bacon Keith Gottesdiener Lisa D. Pedicone Janice K. Albrecht Clifford A. Brass Seth Thompson Margaret H. Burroughs 2012Journal of Hepatology2012,,:2
4Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir显示文摘Fred Poordad Jean–Pierre Bronowicki Stuart C. Gordon Stefan Zeuzem Ira M. Jacobson Mark S. Sulkowski Thierry Poynard Timothy R. Morgan Cliona Molony Lisa D. Pedicone Heather L. Sings Margaret H. Burroughs Vilma Sniukiene Navdeep Boparai Venkata S. Goteti 2012Gastroenterology2012,,3:2
5Boceprevir for Chronic HCV Genotype 1 Infection in Patients with Prior Treatment Failure to Peginterferon/Ribavirin, including Prior Null Response显示文摘John M. Vierling Mitchell Davis Steven Flamm Stuart C. Gordon Eric Lawitz Eric M. Yoshida Joseph Galati Velimir Luketic Jonathan McCone Ira Jacobson Patrick Marcellin Andrew J. Muir Fred Poordad Lisa D. Pedicone Janice Albrecht Clifford Brass Anita Y.M. H 2013Journal of Hepatology2013,,:2
6Scaling diode-pumped, high energy picosecond lasers to kilowatt average powers显示文摘Recent results in the development of diode-driven high energy, high repetition rate, picosecond lasers, including the demonstration of a cryogenic Yb:YAG active mirror amplifier that produces 1.5 J pulses at 500 Hz repetition rate(0.75 kW average power) are reviewed. These pulses are compressed resulting in the generation of ~5 ps duration,1 J pulses with 0.5 kW average power. A full characterization of this high power cryogenic amplifier, including atwavelength interferometry of the active region under >1 kW average power pump conditions, is presented. An initial demonstration of operation at 1 kW average power(1 J, 1 k Hz) is reported.Brendan A.Reagan Cory Baumgarten Elzbieta Jankowska Han Chi Herman Bravo Kristian Dehne Michael Pedicone Liang Yin Hanchen Wang Carmen S.Menoni Jorge J.Rocca 2018High Power Laser Science and Engineering2018,6,1:2
7Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection 显示文摘McHutchison JG Lawitz FJ Shiffman ML Muir AJ Galler GW McCone J Nyberg LM Lee WM Ghalib RH Schiff ER Galati JS Bacon BR Davis MN Mukhopadhyay P Koury K Noviello S Pedicone LD Brass CA Albrecht JK Sulkowski MS IDEAL Study Team 2009N Engl J Med2009,361,6:1
8Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:1
9Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:1
10Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: Meta-analysis of 5 trials显示文摘John M. Vierling Stefan Zeuzem Fred Poordad Jean-Pierre Bronowicki Michael P. Manns Bruce R. Bacon Rafael Esteban Steven L. Flamm Paul Y. Kwo Lisa D. Pedicone Weiping Deng Frank J. Dutko Mark J. DiNubile Kenneth J. Koury Frans A. Helmond Janice Wahl Savin 2014Journal of Hepatology2014,,:1
11Peginterferon-α-2b and Ribavirin for Hepatitis C Recurrence Postorthotopic Liver Transplantation显示文摘Fredric D. Gordon Paul Kwo Reem Ghalib Jeffrey Crippin Hugo E. Vargas Kimberly A. Brown Thomas Schiano Eirum Chaudhri Lisa D. Pedicone Robert S. Brown 2012Journal of Clinical Gastroenterology2012,,8:1
12Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir显示文摘Fred Poordad Jean–Pierre Bronowicki Stuart C. Gordon Stefan Zeuzem Ira M. Jacobson Mark S. Sulkowski Thierry Poynard Timothy R. Morgan Cliona Molony Lisa D. Pedicone Heather L. Sings Margaret H. Burroughs Vilma Sniukiene Navdeep Boparai Venkata S. Goteti 2012Gastroenterology2012,,3:1
13Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:1
14The Association of Genetic Variants with Hepatic Steatosis in Patients with Genotype 1 Chronic Hepatitis C Infection显示文摘Paul Clark Alexander Thompson Qianqian Zhu David Vock Mingfu Zhu Keyur Patel Stephen Harrison Susanna Naggie Dongliang Ge Hans Tillmann Thomas Urban Kevin Shianna Jacques Fellay Zachary Goodman Stephanie Noviello Lisa Pedicone Nezam Afdhal Mark Sulkowski 2012Digestive Diseases and Sciences2012,,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费